{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:34:12Z","timestamp":1773293652784,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":386,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006569.pub4","type":"reference-entry","created":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T06:20:57Z","timestamp":1361600457000},"source":"Crossref","is-referenced-by-count":12,"title":["Aripiprazole versus other atypical antipsychotics for schizophrenia"],"prefix":"10.1002","author":[{"given":"Priya","family":"Khanna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Komossa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Rummel-Kluge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Hunger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hany George","family":"El-Sayeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,2,28]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB1|cit1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4088\/JCP.v68n0104","article-title":"Efficacy and safety of aripiprazole in the acute treatment of schizophrenia in Chinese patients with risperidone as an active control: A randomized trial","volume":"68","author":"Chan","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006569.pub4-BIB2|cit2","first-page":"S497","article-title":"Aripiprazole versus risperidone in the treatment of acutely relapsed patients with schizophrenia in Taiwan: a randomized controlled trial","volume":"14","author":"Hwang","year":"2005","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB3|cit3","unstructured":"BMS A multicenter, double-blind, randomized, comparative study of aripiprazole and olanzapine in the treatment of patients with acute schizophrenia Clinical Study Report CN138003 2005"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB4|cit4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1185\/03007995.2010.537594","article-title":"Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia","volume":"27","author":"Ascher-Svanum","year":"2011","journal-title":"Current Medical Research and Opinion"},{"issue":"7 Suppl","key":"10.1002\/14651858.CD006569.pub4-BIB5|cit5","first-page":"289S","article-title":"A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia","volume":"63","author":"Kane","year":"2008","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub4-BIB6|cit6","series-title":"Proceedings of the 63rd Annual Convention of the Society of Biological Psychiatry","article-title":"A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia","author":"Kane","year":"2008"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB7|cit7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.4088\/JCP.08m04421","article-title":"A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia","volume":"70","author":"Kane","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006569.pub4-BIB8|cit8","first-page":"153","article-title":"A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia","volume":"11","author":"Osuntokun","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB9|cit9","series-title":"Proceedings of the 161st Annual Meeting of the American Psychiatric Association; 2008 May 3-8; Washington DC, USA","article-title":"A 28-week, randomized, double-blind study of olanzapine versus aripiprazole in the treatment of schizophrenia","author":"Watson","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB10|cit10","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00213-006-0428-x","article-title":"The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine","volume":"187","author":"Kern","year":"2006","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB11|cit11","first-page":"421","article-title":"Changes in prolactin levels and arizona sexual experience scale (ASEX) scores among patients switched from risperidone to aripiprazole in the schizophrenia trial of aripiprazole (STAR) study","volume":"33","author":"Beuzen","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB12|cit12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4088\/JCP.v69n0507","article-title":"Predicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of care","volume":"69","author":"Blonde","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB14|cit13","first-page":"432","article-title":"Reasons for switching from previous therapy and preference of medication in the large, randomized, naturalistic schizophrenia trial of aripiprazole (STAR)","volume":"33","author":"Hanssens","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006569.pub4-BIB13|cit14","first-page":"S99","article-title":"Evaluation of quality of life in community-treated schizophrenic patients: a naturalistic, open-label study comparing aripiprazole to standard-of-care (Schizophrenia Trial of aripiprazole: STAR study)","volume":"21","author":"Hanssens","year":"2006","journal-title":"European Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB16|cit15","first-page":"105","article-title":"A multi centre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients. Schizophrenic Trial of aripiprazole: (STAR) study","volume":"11","author":"Kerwin","year":"2008","journal-title":"Wiadomosci Psychiatryczne"},{"issue":"7","key":"10.1002\/14651858.CD006569.pub4-BIB15|cit16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.eurpsy.2007.03.002","article-title":"A multi centre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of aripiprazole: (STAR) study","volume":"22","author":"Kerwin","year":"2007","journal-title":"European Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB17|cit17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1185\/03007995.2010.542745","article-title":"Cost-effectiveness analysis of aripiprazole vs standard-of-care in the management of community-treated patients with schizophrenia: Star study","volume":"27","author":"King","year":"2011","journal-title":"Current Medical Research and Opinion"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub4-BIB18|cit18","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.eurpsy.2008.01.1421","article-title":"Changes in weight and weight-related quality of life in a multi centre, randomized trial of aripiprazole versus standard of care","volume":"23","author":"Kolotkin","year":"2008","journal-title":"European Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB19|cit19","first-page":"439","article-title":"Metabolic effects of aripiprazole versus olanzapine, quetiapine, or risperidone (the STAR trial)","volume":"33","author":"L'Italien","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006569.pub4-BIB20|cit20","first-page":"A538","article-title":"Prevalence of diabetes\/cardiovascular risk factors among schizophrenia patients treated with atypical antipsychotics in a multicenter, randomized, naturalistic, open-label study (Schizophrenia Trial of aripiprazole: STAR study)","volume":"55","author":"L'Italien","year":"2006","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD006569.pub4-BIB21|cit21","unstructured":"L'ltalien GJ Hanssens L Marcus RN McQuade RD Evidence of antipsychotic treatment selection based on metabolic risk factors among community-based schizophrenia patients (The STAR Trial) Proceedings of the 160th Annual Meeting of the American Psychiatric Association; 2007 May 19-24; San Diego, CA 2007"},{"key":"10.1002\/14651858.CD006569.pub4-BIB22|cit22","unstructured":"Millet B A multicenter, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients (Schizophrenia Trial of aripiprazole - STAR) http:\/\/www.clinicaltrials.gov 2005"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB23|cit23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.eurpsy.2008.03.006","article-title":"Preference of medicine and patient-reported quality of life in community-treated schizophrenic patients receiving aripiprazole vs standard of care: results from the STAR study","volume":"23","author":"Taylor","year":"2008","journal-title":"European Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub4-BIB24|cit24","unstructured":"Eli Lilly Company Olanzapine versus aripiprazole in the treatment of acutely ill patients with schizophrenia Eli Lilly and Company Clinical Trial Registry 2004"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB25|cit25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/JCP.0b013e31818aaf6c","article-title":"Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia","volume":"28","author":"Kinon","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB26|cit26","series-title":"Proceedings of the 161st Annual Meeting of the American Psychiatric Association; 2008 May 3-8; Washington DC, USA","article-title":"Olanzapine versus aripiprazole for the treatment of agitation in acutely ill patients with schizophrenia","author":"Stauffer","year":"2008"},{"key":"10.1002\/14651858.CD006569.pub4-BIB27|cit27","series-title":"Proceedings of the Thematic Conference of the World Psychiatric Association on \"Treatments in Psychiatry: An Update\"; 2004 Nov 10-13; Florence, Italy","article-title":"Comparative study of the long-term effects of aripiprazole and olanzapine treatment on body weight","author":"Abou Gharbia","year":"2004"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006569.pub4-BIB28|cit28","doi-asserted-by":"crossref","first-page":"S275","DOI":"10.1016\/S0924-977X(04)80317-1","article-title":"The risk of new-onset type 2 diabetes and coronary heart disease in chronic schizophrenic patients treated with aripiprazole and olanzapine","volume":"14","author":"Blonde","year":"2004","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB29|cit29","first-page":"187","article-title":"Long-term weight effects of aripiprazole versus olanzapine","volume":"67","author":"Jody","year":"2004","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006569.pub4-BIB30|cit30","series-title":"Proceedings of the 156th Annual Meeting of the American Psychiatric Association; 2003 May 17-22; San Francisco, California, USA","article-title":"Long-term weight effects of aripiprazole versus olanzapine","author":"McQuade","year":"2003"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB31|cit31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0920-9964(03)80498-X","article-title":"Aripiprazole for long-term maintenance treatment of schizophrenia","volume":"60","author":"McQuade","year":"2003","journal-title":"Schizophrenia Research"},{"issue":"Suppl 18","key":"10.1002\/14651858.CD006569.pub4-BIB32|cit32","first-page":"47","article-title":"A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study","volume":"65","author":"McQuade","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl 18","key":"10.1002\/14651858.CD006569.pub4-BIB33|cit33","first-page":"47","article-title":"A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study","volume":"65","author":"McQuade","year":"2004","journal-title":"Journal of Clinical Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB34|cit34","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4088\/JCP.08m04267","article-title":"The moderating impact of ethnicity on metabolic outcomes during treatment with olanzapine and aripiprazole in patients with schizophrenia","volume":"70","author":"Meyer","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub4-BIB35|cit35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0920-9964(03)80511-X","article-title":"Aripiprazole and risperidone versus placebo in schizophrenia and schizoaffective disorder","volume":"60","author":"Potkin","year":"2003","journal-title":"Schizophrenia Research"},{"issue":"7","key":"10.1002\/14651858.CD006569.pub4-BIB36|cit36","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.60.7.681","article-title":"Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder","volume":"60","author":"Potkin","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB37|cit37","first-page":"157","article-title":"Broad effectiveness trial with aripiprazole","volume":"67","author":"Riera","year":"2004","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB38|cit38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.schres.2005.12.857","article-title":"A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With aripiprazole (BETA)","volume":"84","author":"Tandon","year":"2006","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006569.pub4-BIB39|cit39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-006-0564-3","article-title":"Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine","volume":"189","author":"Chrzanowski","year":"2006","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB40|cit40","series-title":"Proceedings of the 13th Biennial Winter Workshop on Schizophrenia Research; 2006 Feb 4-10; Davos, Switzerland","article-title":"Aripiprazole vs olanzapine in patients with acutely relapsing or chronic, stable schizophrenia: A 52-week open-label extension study","author":"Sanchez","year":"2006"},{"key":"10.1002\/14651858.CD006569.pub4-BIB41|cit41","series-title":"Proceedings of the 13th Congress of the Association of European Psychiatrists; 2005 Apr 2-6; Munich, Germany","article-title":"Broad effectiveness trial with aripiprazole in Europe Eu-Beta","author":"Beuzen","year":"2005"},{"key":"10.1002\/14651858.CD006569.pub4-BIB42|cit42","series-title":"Proceedings of the XIII World Congress of Psychiatry; 2005 Sep 10-15; Cairo, Egypt","article-title":"Naturalistic study of aripiprazole treatment","author":"Beuzen","year":"2005"},{"key":"10.1002\/14651858.CD006569.pub4-BIB43|cit43","series-title":"Proceedings of the 13th Biennial Winter Workshop on Schizophrenia Research; 2006 Feb 4-10; Davos, Switzerland","article-title":"Effectiveness of aripiprazole in a naturalistic setting: a European multicenter study","author":"Beuzen","year":"2006"},{"issue":"10","key":"10.1002\/14651858.CD006569.pub4-BIB44|cit44","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1185\/030079907X225448","article-title":"A prospective, multi centre, open-label study of aripiprazole in the management of patients with schizophrenia in psychiatric practice in Europe: Broad Effectiveness Trial with aripiprazole in Europe (EU-BETA)","volume":"23","author":"Wolf","year":"2007","journal-title":"Current Medical Research and Opinion"},{"key":"10.1002\/14651858.CD006569.pub4-BIB45|cit45","unstructured":"Pfizer A study comparing the efficacy and safety of ziprasidone and aripiprazole for the treatment of schizophrenia or schizoaffective disorder in hospitalized patients http:\/\/www.clinicaltrials.gov 2008"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB46|cit46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/YIC.0b013e32816f7779","article-title":"Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: A randomized, double-blind, 4-week study","volume":"22","author":"Zimbroff","year":"2007","journal-title":"International Clinical Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB47|cit47","first-page":"418","article-title":"Similar rates of agitation, anxiety and insomnia in sedating and non-sedating antipsychotics: evaluating clinical trial results with aripiprazole, haloperidol and olanzapine","volume":"33","author":"Allen","year":"2007","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD006569.pub4-BIB48|cit48","unstructured":"Anon Effectiveness of antipsychotic combination with psychosocial intervention on outcome of patients with schizophrenia http:\/\/www.clinicaltrials.gov 2008"},{"key":"10.1002\/14651858.CD006569.pub4-BIB49|cit49","unstructured":"Bergman M Friedman JI Stawarz K Bowman A Siever L Cavagna M A double blind placebo controlled study of guanfacine adjunctive treatment to atypical antipsychotics for cognitive dysfunction in schizophrenia http:\/\/www.clinicaltrials.gov 2007"},{"key":"10.1002\/14651858.CD006569.pub4-BIB50|cit50","unstructured":"Bristol-Myers Squibb Otsuka America Pharmaceutical A multicenter, randomized, double-blind, placebo-controlled, 16 week study of aripiprazole used as dual therapy in the treatment of patients with chronic stable schizophrenia or schizoaffective disorder demonstrating an inadequate response to quetiapine or risperidone monotherapy http:\/\/www.clinicaltrials.gov 2006"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006569.pub4-BIB51|cit51","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.1016\/S0924-977X(00)80358-2","article-title":"Efficacy of aripiprazole in psychotic disorders: comparison with haloperidol and placebo","volume":"10","author":"Carson","year":"2000","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB52|cit52","series-title":"Proceedings of the 156th Annual Meeting of the American Psychiatric Association; 2003 May 17- 22; San Francisco, California, USA","article-title":"Metabolic syndrome comparison between olanzapine, aripiprazole, and placebo","author":"Casey","year":"2003"},{"key":"10.1002\/14651858.CD006569.pub4-BIB53|cit53","first-page":"845","article-title":"A multi centre, randomised and double-blind controlled trial of aripiprazole in treatment of schizophrenia","volume":"11","author":"Chen","year":"2005","journal-title":"Chinese Journal of New Drugs and Clinical Remedies"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB54|cit54","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2147\/NDT.S3701","article-title":"An economic evaluation of aripiprazole vs olanzapine adapted to the Italian setting using outcomes of metabolic syndrome and risk for diabetes in patients with schizophrenia","volume":"4","author":"Colombo","year":"2008","journal-title":"Neuropsychiatric Disease and Treatment"},{"issue":"3 Suppl 1","key":"10.1002\/14651858.CD006569.pub4-BIB55|cit55","first-page":"27","article-title":"Neurocognitive effects of aripiprazole versus olanzapine in patients with stable psychosis","volume":"53","author":"Cornblatt","year":"2002","journal-title":"Schizophrenia Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006569.pub4-BIB56|cit56","first-page":"NRS5.4","article-title":"Aripiprazole, olanzapine and olanzapine-clomipramine combination in schizophrenia with obsessive-compulsive symptoms","volume":"8","author":"Fawzi","year":"2009","journal-title":"World Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub4-BIB57|cit57","doi-asserted-by":"crossref","first-page":"S447","DOI":"10.1016\/S0924-977X(08)70660-6","article-title":"Long-term effect on weight of aripiprazole-clozapine in schizophrenia patients with suboptimal response on clozapine","volume":"18","author":"Fleischhacker","year":"2008","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB58|cit58","unstructured":"Markovic O A multicenter, comparative, randomized, double-blind, placebo controlled study on the effect on weight of adjunctive treatment with aripiprazole in patients with schizophrenia http:\/\/www.clinicaltrials.gov 2006"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB59|cit59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.schres.2009.05.030","article-title":"Effectiveness of second-generation antipsychotics with acute-phase schizophrenia","volume":"113","author":"Hatta","year":"2009","journal-title":"Schizophrenia Research"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB60|cit60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/JCP.0b013e31819a8dbe","article-title":"Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients","volume":"29","author":"Henderson","year":"2009","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB61|cit61","unstructured":"Roussel JJ Machon DA Henderson DC A placebo-controlled, cross-over trial of aripiprazole added to obese olanzapine-treated patients with schizophrenia http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub4-BIB62|cit62","unstructured":"Janssen F A comparative, randomized, open-label, multicenter study on the efficacy and safety of switch treatment with aripiprazole in schizophrenic out-patients who are experiencing insufficient efficacy with risperidone and\/or safety and tolerability issues, while on risperidone http:\/\/www.clinicaltrials.gov 2005"},{"key":"10.1002\/14651858.CD006569.pub4-BIB63|cit63","unstructured":"Kim YS A double-blind randomized placebo controlled study of aripiprazole augmentation for clozapine-treated patients with refractory schizophrenia http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub4-BIB64|cit64","unstructured":"Kim C-Y A multi-center, randomized, open, treatment-switching study from orally administered antipsychotic monotherapy in the treatment of chronic schizophrenic and schizoaffective patients http:\/\/www.clinicaltrials.gov 2006"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB65|cit65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/YIC.0b013e32832c25d7","article-title":"A 12-week, naturalistic switch study of the efficacy and tolerability of aripiprazole in stable outpatients with schizophrenia or schizoaffective disorder","volume":"24","author":"Kim","year":"2009","journal-title":"International Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB66|cit66","doi-asserted-by":"crossref","first-page":"S440","DOI":"10.1016\/S0924-977X(08)70647-3","article-title":"Prolactin level as an indicator to clinical psychopathological severity in aripiprazole treated schizophrenia","volume":"18","author":"Lan","year":"2008","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB67|cit67","unstructured":"Liang S A multi-center, randomized, double-blind study, comparing with risperidone, to evaluate the efficacy and safety of aripiprazole in the treatment of patients with schizophrenia http:\/\/www.clinicaltrials.gov 2005"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB68|cit68","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0031-1271688","article-title":"An open randomized pilot trial on the differential effects of aripiprazole versus risperidone on anhedonia and subjective well-being","volume":"44","author":"Liemburg","year":"2011","journal-title":"Pharmacopsychiatry"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub4-BIB69|cit69","first-page":"1046, 1048","article-title":"A study of aripiprazole combined with clozapine in refractory schizophrenia","volume":"19","author":"Ma","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"key":"10.1002\/14651858.CD006569.pub4-BIB70|cit70","series-title":"Proceedings of the 161st Annual Meeting of the American Psychiatric Association; 2008 May 3-8; Washington DC, USA","article-title":"Relapse prevention and effectiveness in schizophrenia of risperidone long-acting injectable (rlai) versus quetiapine or aripiprazole","author":"Medori","year":"2008"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB71|cit71","first-page":"A17","article-title":"The effects of aripiprazole in combination with clozapine: patient functioning results from a double-blind, 16-week study in patients with schizophrenia (CN138-170)","volume":"22","author":"Millar","year":"2008","journal-title":"Journal of Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB72|cit72","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/ebmh.7.2.41","article-title":"Aripiprazole is effective for relapse prevention in people with chronic stable schizophrenia","volume":"7","author":"Mortimer","year":"2004","journal-title":"Evidence-Based Mental Health"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB73|cit73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/FPC.0b013e328311a917","article-title":"Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia","volume":"19","author":"Mossner","year":"2009","journal-title":"Pharmacogenetics and Genomics"},{"key":"10.1002\/14651858.CD006569.pub4-BIB74|cit74","unstructured":"Namey LB Henderson DC Aripiprazole for clozapine associated medical morbidity http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub4-BIB75|cit75","series-title":"Proceedings of the 159th Annual Meeting of the American Psychiatric Association; 2006 May 20-25; Toronto, Canada","article-title":"Improvement of non-hdl cholesterol levels among patients randomized to aripiprazole versus olanzapine","author":"Newcomer","year":"2006"},{"issue":"2-3","key":"10.1002\/14651858.CD006569.pub4-BIB76|cit76","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.schres.2008.09.002","article-title":"Changes in non-high-density lipoprotein cholesterol levels and triglyceride\/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine","volume":"106","author":"Newcomer","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"2-3","key":"10.1002\/14651858.CD006569.pub4-BIB77|cit77","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.schres.2008.09.002","article-title":"Changes in non-high-density lipoprotein cholesterol levels and triglyceride\/high-density lipoprotein cholesterol ratios among patients randomized to aripiprazole versus olanzapine","volume":"106","author":"Newcomer","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub4-BIB78|cit78","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.euroneuro.2009.04.002","article-title":"Immediate versus gradual suspension of previous treatments during switch to aripiprazole: results of a randomized, open label study","volume":"19","author":"Pae","year":"2009","journal-title":"European Neuropsychopharmacology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD006569.pub4-BIB79|cit79","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.1016\/S0924-977X(04)80327-4","article-title":"An economic evaluation of aripiprazole compared to olanzapine based on metabolic side-effect profile","volume":"14","author":"Ray","year":"2004","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB80|cit80","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ebmh.12.2.51","article-title":"Refractory schizophrenia: Adding aripiprazole to clozapine reduces negative but not overall symptoms","volume":"12","author":"Remington","year":"2009","journal-title":"Evidence-Based Mental Health"},{"key":"10.1002\/14651858.CD006569.pub4-BIB81|cit81","series-title":"Proceedings of the 9th World Congress of Biological Psychiatry; 2009 Jun 28-Jul 2; Paris, France","article-title":"Descriptive analyses of the aripiprazole arm in the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)","author":"Schreiner","year":"2009"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD006569.pub4-BIB82|cit82","doi-asserted-by":"crossref","first-page":"S405","DOI":"10.1016\/S0924-977X(06)70504-1","article-title":"Adjunctive treatment with a dopamine partial agonist, aripiprazole for antipsychotic induced hyperprolactinemia","volume":"16","author":"Shim","year":"2006","journal-title":"European Neuropsychopharmacology"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB83|cit83","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/JCP.0b013e3181842586","article-title":"A randomized, open-label comparison of 2 switching strategies to aripiprazole treatment in patients with schizophrenia: add-on, wait, and tapering of previous antipsychotics versus add-on and simultaneous tapering","volume":"28","author":"Takeuchi","year":"2008","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB84|cit84","unstructured":"Talbott S Buckley P Eudicone J McQuade R Van-Tran Q Akathisia in schizophrenia patients treated with aripiprazole, haloperidol, or olanzapine-analyses of the first 12 weeks of three double-blind, long-term trials Proceedings of the 11th International Congress on Schizophrenia Research; 2007 Mar 28-Apr 1; Colorado Springs, Colorado, USA 2007"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB85|cit85","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/ebmh.10.3.76","article-title":"Haloperidol, olanzapine and risperidone reduce treatment failure compared to aripiprazole, quetiapine and ziprasidone in acute schizophrenia","volume":"10","author":"Taylor","year":"2007","journal-title":"Evidence-Based Mental Health"},{"key":"10.1002\/14651858.CD006569.pub4-BIB86|cit86","unstructured":"Watts KL Wilson H Tang T Estimating and reducing the cardiovascular risk of patients with schizophrenia drugs from lipid measures and ischemic electrocardiographic changes http:\/\/www.clinicaltrials.gov 2006"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB87|cit87","first-page":"15","article-title":"A control study of aripiprazole vs. clozapine in the treatment of refractory schizophrenia","volume":"13","author":"Yang","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB88|cit88","first-page":"53","article-title":"Comparison study in the treatment of schizophrenia between aripiprazole and clozapine","volume":"18","author":"Ai","year":"2008","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34 \u5e8a \u7cbe \u795e \u533b \u5b66 \u6742 \u5fd7 ]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB89|cit89","first-page":"213","article-title":"Controlled study of clozapine and aripiprazole in the treatment of schizophrenia","volume":"11","author":"An","year":"2008","journal-title":"\u5b9e \u7528 \u836f \u7269 \u4e0e \u4e34 \u5e8a"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB90|cit90","first-page":"39","article-title":"Comparative study on the efficacy of aripiprazole and clozapine in treatment of schizophrenia","volume":"1","author":"\u767d \u6811 \u65b0","year":"2007","journal-title":"\u4e2d \u56fd \u4e34 \u5e8a \u5b9e \u7528 \u533b \u5b66"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB91|cit91","first-page":"292","article-title":"Analysis of the efficacy of aripiprazole and quetiapine in the treatment of schizophrenia","volume":"24","author":"Ban","year":"2008","journal-title":"Occupation and Health [\u804c \u4e1a \u4e0e \u5065 \u5eb7 ]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB92|cit92","first-page":"198","article-title":"The effectiveness of aripiprazole combined with clonazepam treated with agitation in schizophrenia","volume":"19","author":"Bao","year":"2007","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB93|cit93","first-page":"335","article-title":"A control study of aripiprazole vs. risperidone in the treatment of schizophrenia","volume":"13","author":"Chang","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34 \u5e8a \u5fc3 \u8eab \u75be \u75c5 \u6742 \u5fd7 ]"},{"issue":"9","key":"10.1002\/14651858.CD006569.pub4-BIB94|cit94","first-page":"404","article-title":"Comparative study of therapeutic effects between aripiprazole and risperidone on schizophrenia","volume":"27","author":"Chen","year":"2006","journal-title":"Shanghai Medical and Pharmaceutical Journal"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB95|cit95","first-page":"97","article-title":"A comparative study of aripiprazole and clozapine in the treatment of first-episode schizophrenia","volume":"20","author":"Chen","year":"2007","journal-title":"Shandong Archives of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB96|cit96","first-page":"394","article-title":"A comparative study of aripiprazole and risperidone in the treatment of the first episode schizophrenia","volume":"20","author":"Chen","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB97|cit97","first-page":"261","article-title":"Comparative study between aripiprazole and olanzapine in the treatment of agitated schizophrenia","volume":"19","author":"\u9648 \u8fdc \u5cad","year":"2009","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34 \u5e8a \u7cbe \u795e \u533b \u5b66 \u6742 \u5fd7 ]"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub4-BIB98|cit98","first-page":"712","article-title":"Comparison of efficacy and safety of aripiprazole and quetiapine in the treatment of schizophrenia","volume":"14","author":"Dai","year":"2005","journal-title":"Chinese Journal of Behavioral Medical Science"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB99|cit99","first-page":"14","article-title":"A comparison of schizophrenia with aripiprazole and risperidone","volume":"26","author":"Dai","year":"2006","journal-title":"Journal of the Datong Medical College"},{"issue":"13","key":"10.1002\/14651858.CD006569.pub4-BIB100|cit100","first-page":"1065","article-title":"Study on effects of aripiprazole on serum prolactin level and body weight","volume":"9","author":"Du","year":"2006","journal-title":"Chinese General Practice"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB101|cit101","first-page":"377","article-title":"Efficacy analysis of aripiprazole and clozapine in the treatment of schizophrenia","volume":"20","author":"Fan","year":"2005","journal-title":"Journal of North Sichuan Medical College"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB102|cit102","first-page":"418","article-title":"The clinical study on aripiprazole and risperidone in treatment of first-onset schizophrenia","volume":"14","author":"Feng","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB103|cit103","first-page":"241","article-title":"A controlled study of efficacy between aripiprazole and risperidone in the treatment of patients","volume":"17","author":"Guan","year":"2007","journal-title":"Linchuang Jingshen Yixue Zazhi"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB104|cit104","first-page":"716","article-title":"A randomized and double-blind controlled clinical trial of aripiprazole in the treatment of schizophrenia","volume":"23","author":"Guo","year":"2006","journal-title":"Hunan Medical Journal"},{"issue":"10","key":"10.1002\/14651858.CD006569.pub4-BIB105|cit105","first-page":"853","article-title":"A controlled study of schizophrenia treated with aripiprazole and clozapine","volume":"11","author":"Han","year":"2005","journal-title":"Clinical Journal of Rehabilitation in Theory and Practice"},{"issue":"11","key":"10.1002\/14651858.CD006569.pub4-BIB106|cit106","first-page":"995","article-title":"Quality of life in schizophrenics treated with aripiprazole or clozapine","volume":"12","author":"Han","year":"2006","journal-title":"Chinese Journal of Rehabilitation Theory and Practice"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB107|cit107","first-page":"28","article-title":"Clinical effect of the domestic olanzapine and aripiprazole in the treatment of schizophrenia","volume":"15","author":"Han","year":"2007","journal-title":"Chinese Journal of Health Psychology"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB108|cit108","first-page":"77","article-title":"Clinical efficacy of aripiprazole and risperidone in treating schizophrenia and their influence","volume":"10","author":"Huang","year":"2008","journal-title":"\u836f \u7269 \u4e0d \u826f \u53cd \u5e94 \u6742 \u5fd7"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB109|cit109","first-page":"261","article-title":"A study of aripiprazole and risperidone in treatment of schizophrenia","volume":"17","author":"Ji","year":"2007","journal-title":"Linchuang Jingshen Yixue Zazhi"},{"issue":"10","key":"10.1002\/14651858.CD006569.pub4-BIB110|cit110","first-page":"1147","article-title":"A comparison between the therapeutic effects of aripiprazole and risperidone in the treatment of schizophrenia","volume":"26","author":"Jiang","year":"2007","journal-title":"Herald of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB111|cit111","first-page":"426","article-title":"A controlled study on compliance of schizophrenia treated with aripiprazole and clozapine","volume":"14","author":"Kuang","year":"2006","journal-title":"Chinese Journal of Clinical Psychology"},{"issue":"9","key":"10.1002\/14651858.CD006569.pub4-BIB112|cit112","first-page":"690","article-title":"A controlled study on quality of life of schizophrenia treated with aripiprazole and clozapine","volume":"18","author":"Kuang","year":"2006","journal-title":"Medical Journal of Chinese Civil Administration"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB113|cit113","first-page":"196","article-title":"A comparative study of aripiprazole and risperidone in the treatment of first-episode schizophrenia","volume":"19","author":"Li","year":"2006","journal-title":"Shandong Archives of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD006569.pub4-BIB114|cit114","first-page":"723","article-title":"A comparative study of aripiprazole and risperidone in the treatment of schizophrenia","volume":"18","author":"Li","year":"2006","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB115|cit115","first-page":"170","article-title":"A comparative study on quality of life of female schizophrenics treated with aripiprazole","volume":"19","author":"Li","year":"2007","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB116|cit116","first-page":"165","article-title":"A controlled study of domestic aripiprazole and clozapine in the treatment of refractory schizophrenia","volume":"19","author":"Li","year":"2007","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"10","key":"10.1002\/14651858.CD006569.pub4-BIB117|cit117","first-page":"956","article-title":"Comparative study of influence of aripiprazole on life quality in schizophrenic patients","volume":"15","author":"Li","year":"2007","journal-title":"Chinese Journal of Health Psychology"},{"issue":"11","key":"10.1002\/14651858.CD006569.pub4-BIB118|cit118","first-page":"77","article-title":"Comparison of efficacy and safety of aripiprazole and ziprasidone in the treatment of schizophrenia","volume":"13","author":"Li","year":"2007","journal-title":"International Medicine and Health Guidance News"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB119|cit119","first-page":"100","article-title":"Control studies of domestic aripiprazole vs. risperidone in the treatment of schizophrenia","volume":"13","author":"Li","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB120|cit120","first-page":"404","article-title":"Effects of aripiprazole and clozapine on life quality of schizophrenics","volume":"13","author":"Li","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34 \u5e8a \u5fc3 \u8eab \u75be \u75c5 \u6742 \u5fd7 ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB121|cit121","first-page":"660","article-title":"A controlIed study of aripiprazole and risperidone in treatment of first-episode schizophrenia","volume":"14","author":"Lin","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB122|cit122","first-page":"420","article-title":"A control study on aripiprazole and risperidone in the treatment of schizophrenia","volume":"14","author":"Liu","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB123|cit123","first-page":"658","article-title":"Comparative study between aripiprazole and clozapine in the treatment of first-episode schizophrenia","volume":"14","author":"Liu","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub4-BIB124|cit124","first-page":"36","article-title":"A comparison study on the efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia","volume":"7","author":"Liu","year":"2007","journal-title":"Modern Hospital"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB125|cit125","first-page":"500-1, 507","article-title":"A control study on aripiprazole vs. clozapine in the treatment of refractory schizophrenia","volume":"13","author":"Liu","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34 \u5e8a \u5fc3 \u8eab \u75be \u75c5 \u6742 \u5fd7 ]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB126|cit126","first-page":"142","article-title":"Compared effect and safety analysis of aripiprazole in late-onset schizophrenia","volume":"20","author":"Liu","year":"2007","journal-title":"Sichuan Mental Health"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB127|cit127","first-page":"124","article-title":"A comparative study of ziprasidone and aripiprazole in the treatment of schizophrenia with predominantly negative symptoms","volume":"16","author":"Liu","year":"2008","journal-title":"Chinese Journal of Health Psychology [\u4e2d \u56fd \u5065 \u5eb7 \u5fc3 \u7406 \u5b66 \u6742 \u5fd7 ]"},{"issue":"20","key":"10.1002\/14651858.CD006569.pub4-BIB128|cit128","first-page":"1709","article-title":"Effect of aripiprazole on late-onset schizophrenia and cognitive function","volume":"16","author":"Lou","year":"2007","journal-title":"Chinese New Drugs Journal"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB129|cit129","first-page":"191","article-title":"Comparison of quetiapine and aripiprazole in the treatment of first episode schizophrenia","volume":"18","author":"Luo","year":"2008","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34 \u5e8a \u7cbe \u795e \u533b \u5b66 \u6742 \u5fd7 ]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB130|cit130","first-page":"181","article-title":"Effect of aripiprazole on body weight and blood glucose in the treatment of first-episode schizophrenia","volume":"19","author":"Lv","year":"2006","journal-title":"Shandong Archives of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB131|cit131","first-page":"181","article-title":"A comparative study on aripiprazole and risperidone in the treatment of schizophrenic patients","volume":"19","author":"Lv","year":"2007","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB132|cit132","first-page":"184","article-title":"Comparative study on the effect of aripiprazole and risperidone on schizophrenia","volume":"20","author":"Mai","year":"2005","journal-title":"Chinese Journal of Rehabilitation"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB133|cit133","first-page":"363","article-title":"A controlled study of aripiprazole and risperdal in the treatment of schizophrenia","volume":"15","author":"Pan","year":"2007","journal-title":"Chinese Journal of Health Psychology"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB134|cit134","first-page":"329","article-title":"A clinical analysis of aripiprazole and quetiapine in treatment of first episode schizophrenia","volume":"17","author":"Peng","year":"2007","journal-title":"Linchuang Jingshen Yixue Zazhi"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB135|cit135","first-page":"237","article-title":"Comparative study between aripiprazole and clozapine in the treatment of schizophrenia","volume":"27","author":"Peng","year":"2007","journal-title":"Journal of the Gannan Medical College"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB136|cit136","first-page":"163-4, 7","article-title":"The comparison of blood prolactin and body index in the female patients with psychosis treated by aripiprazole and risperidone","volume":"19","author":"Pu","year":"2007","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB137|cit137","first-page":"119-20, 133","article-title":"A controlled study of aripiprazole vs. risperidone in the treatment of schizophrenia","volume":"14","author":"Shang","year":"2008","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34 \u5e8a \u5fc3 \u8eab \u75be \u75c5 \u6742 \u5fd7 ]"},{"issue":"7","key":"10.1002\/14651858.CD006569.pub4-BIB138|cit138","first-page":"714","article-title":"A controlled study on aripiprazole and risperidone in the treatment of schizophrenic patients","volume":"23","author":"Shen","year":"2006","journal-title":"Chinese Journal of Modern Applied Pharmacy"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB139|cit139","first-page":"35","article-title":"Evaluating the effect and safety of aripirazole and risperidone","volume":"10","author":"Shuai","year":"2008","journal-title":"\u4e2d \u56fd \u73b0 \u4ee3 \u533b \u836f \u6742 \u5fd7"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB140|cit140","first-page":"337","article-title":"Clinical study of aripiprazole in treatment of hyperprolactinem ia caused by risperidone","volume":"18","author":"Song","year":"2008","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34 \u5e8a \u7cbe \u795e \u533b \u5b66 \u6742 \u5fd7 ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB141|cit141","first-page":"409","article-title":"A comparative study of olanzapine and aripiprazole in treatment of schizophrenia","volume":"18","author":"Su","year":"2008","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34 \u5e8a \u7cbe \u795e \u533b \u5b66 \u6742 \u5fd7 ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB142|cit142","first-page":"642","article-title":"A randomized control study aripiprazole in the treatment of first-episode schizophrenia","volume":"14","author":"Sun","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB143|cit143","first-page":"424","article-title":"Effect of aripiprazole on cognition function in patients with schizophrenic","volume":"14","author":"Sun","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB144|cit144","first-page":"30","article-title":"Aripiprazole and risperidone in the treatment of female schizophrenics","volume":"18","author":"Tang","year":"2006","journal-title":"Shanghai Archives of Psychiatry"},{"issue":"17","key":"10.1002\/14651858.CD006569.pub4-BIB145|cit145","first-page":"727","article-title":"Comparison of efficacy and safety of aripiprazole and risperidone in the treatment of schizophrenia","volume":"19","author":"Tang","year":"2007","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB146|cit146","first-page":"13","article-title":"Aripiprazole and risperidone in the treatment efficacy of first-episode schizophrenia","volume":"19","author":"Tang","year":"2010","journal-title":"Chinese Journal of Pharmaco Epidemiology [\u836f \u7269 \u6d41 \u884c \u75c5 \u5b66 \u6742 \u5fd7 ]"},{"key":"10.1002\/14651858.CD006569.pub4-BIB147|cit147","first-page":"927","article-title":"A comparison of the effects on lipid metabolic among four different atypical antipsychotic agents","volume":"6","author":"Tao","year":"2008","journal-title":"Journal of the Youjiang Medical College for Nationalities"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB148|cit148","first-page":"7","article-title":"Control study of aripiprazole and risperidone in the treatment of schizophrenia","volume":"13","author":"Tong","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB149|cit149","first-page":"301","article-title":"A controlled study of aripiprazole vs clozapine in the treatment of first-episode schizophrenia","volume":"11","author":"Wang","year":"2005","journal-title":"Journal of Clinical Psychosomatic"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB150|cit150","first-page":"650","article-title":"A comparative study between aripiprazole and risperidone in the treatment of chronic schizophrenia","volume":"14","author":"Wang","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB151|cit151","first-page":"245","article-title":"A controlled study of aripiprazole and risperidone in the treatment of schizophrenia","volume":"12","author":"Wang","year":"2006","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB152|cit152","first-page":"108","article-title":"Clinical study of aripiprazole and risperidone in treatment of schizophrenia","volume":"16","author":"Wang","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB153|cit153","first-page":"44","article-title":"Comparative study between aripiprazole and clozapine in the treatment of patients with schizophrenia","volume":"16","author":"Wang","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB154|cit154","first-page":"360","article-title":"Effect of aripiprazole on quality of life of schizophrenic patients","volume":"16","author":"Wang","year":"2006","journal-title":"Linchuang Jingshen Yixue Zazhi"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB155|cit155","first-page":"427","article-title":"Observation of therapeutic effect of aripiprazole in the treatment schizophrenic patients","volume":"14","author":"Wang","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"17","key":"10.1002\/14651858.CD006569.pub4-BIB156|cit156","first-page":"751","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"19","author":"Wang","year":"2007","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB157|cit157","first-page":"154","article-title":"A controlled study of effect on serum prolactin level between aripiprazole and risperidone","volume":"17","author":"Wang","year":"2007","journal-title":"Linchuang Jingshen Yixue Zazhi"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB158|cit158","first-page":"42","article-title":"Comparative study on aripiprazole and risperidone in treatment of female schizophrenia","volume":"19","author":"Wang","year":"2007","journal-title":"\u897f \u90e8 \u533b \u5b66"},{"issue":"32","key":"10.1002\/14651858.CD006569.pub4-BIB159|cit159","first-page":"2487","article-title":"Non-classical antipsychotic drugs for schizophrenia: cost - minimization analysis on 3 schemes","volume":"18","author":"Wang","year":"2007","journal-title":"China Pharmacy [\u4e2d \u570b \u85e5 \u623f ]"},{"issue":"21","key":"10.1002\/14651858.CD006569.pub4-BIB160|cit160","first-page":"38","article-title":"A controlled study of effect on schizophrenia serum prolactin level aripiprazole","volume":"3","author":"Wang","year":"2008","journal-title":"\u4e2d \u56fd \u5b9e \u7528 \u533b \u836f"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB161|cit161","first-page":"511","article-title":"A randomized, double blind, double dummy parallel controlled study in the female first-episode schizophrenia treated with aripiprazole and quetiapine","volume":"32","author":"Wei","year":"2006","journal-title":"Chinese Journal of Nervous and Mental Diseases"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB162|cit162","first-page":"194","article-title":"A randomized, double blind, double dummy parallel controlled study in the female first-onset schizophrenia treated with aripiprazole and quetiapine","volume":"6","author":"Wei","year":"2006","journal-title":"Nervous Diseases and Mental Hygjene"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB163|cit163","first-page":"342","article-title":"Comparison of aripiprazole and risperidone in the treatment of female schizophrenia","volume":"24","author":"\u6587 \u5bb6 \u677e","year":"2009","journal-title":"Journal of the North Sichuan Medical College"},{"issue":"15","key":"10.1002\/14651858.CD006569.pub4-BIB164|cit164","first-page":"1723","article-title":"A comparative study of aripiprazole and risperidone in the treatment of senile schizophrenia","volume":"20","author":"Wu","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB165|cit165","first-page":"28","article-title":"Comparative study on the clinical effect and the life quality of schizophrenic patients treated with aripiprazole and clozapine","volume":"1","author":"Xiao","year":"2007","journal-title":"\u4e2d \u56fd \u533b \u7597 \u524d \u6cbf"},{"issue":"19","key":"10.1002\/14651858.CD006569.pub4-BIB166|cit166","first-page":"1629","article-title":"Comparative study of aripiprazole and risperidone for schizophrenia","volume":"29","author":"Xu","year":"2008","journal-title":"Jilin Medical Journal"},{"issue":"17","key":"10.1002\/14651858.CD006569.pub4-BIB167|cit167","first-page":"2180","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"22","author":"\u9648 \u6069 \u6c11","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB168|cit168","first-page":"92","article-title":"A comparative between aripiprazole and clozapine in the treatment of schizophrenia","volume":"19","author":"Yang","year":"2006","journal-title":"Sichuan Mental Health"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB169|cit169","first-page":"942","article-title":"A randomized controlled clinical study of aripiprazole in the treatment of childhood schizophrenia","volume":"24","author":"Yang","year":"2007","journal-title":"Hunan Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB170|cit170","first-page":"234","article-title":"Control study of aripiprazole and clozapine in treatment of patients with schizophrenia","volume":"19","author":"Yang","year":"2007","journal-title":"\u897f \u90e8 \u533b \u5b66"},{"issue":"23","key":"10.1002\/14651858.CD006569.pub4-BIB171|cit171","first-page":"2760","article-title":"A comparative study of ziprasidone and aripiprazole in the treatment of schizophrenia","volume":"20","author":"Yang","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB172|cit172","first-page":"52","article-title":"Study of aripiprazole in treatment of first-episode schizophrenia","volume":"17","author":"Yang","year":"2008","journal-title":"China Pharmaceuticals [\u4e2d \u570b \u85e5 \u696d ]"},{"key":"10.1002\/14651858.CD006569.pub4-BIB173|cit173","first-page":"616","article-title":"A comparative study between aripiprazole and risperidone in treatment of first-onset schizophrenia","volume":"6","author":"Ye","year":"2005","journal-title":"Wutaishan Hospital in Yangzhou City"},{"issue":"24","key":"10.1002\/14651858.CD006569.pub4-BIB174|cit174","first-page":"3199","article-title":"Controlled study between aripiprazole and olanzapine on schizophrenia","volume":"14","author":"Ye","year":"2005","journal-title":"Modern Research of Integrated Chinese and Western Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB175|cit175","first-page":"253","article-title":"A comparative study of blood-glucose metabolism between aripiprazole and clozapine in treatment of patients with schizophrenia","volume":"17","author":"Yi","year":"2007","journal-title":"Linchuang Jingshen Yixue Zazhi"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB176|cit176","first-page":"422","article-title":"Effects of aripiprazole vs. clozapine on body weight and blood sugar levels of schizophrenics","volume":"12","author":"Yu","year":"2006","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB177|cit177","first-page":"263","article-title":"The study of clinical efficacy of aripiprazole in the treatment for refractory schizophrenia","volume":"19","author":"Yu","year":"2006","journal-title":"Shandong Jingshen Yixue"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB178|cit178","first-page":"115","article-title":"A control study of aripiprazole and clozapine in the treatment of first-episode schizophrenia","volume":"13","author":"Yu","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"10","key":"10.1002\/14651858.CD006569.pub4-BIB179|cit179","first-page":"948","article-title":"Comparative study of aripiprazole and risperidone in the treatment of female schizophrenias","volume":"15","author":"Yu","year":"2007","journal-title":"Chinese Journal of Health Psychology"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB180|cit180","first-page":"288","article-title":"Influence of aripiprazole on life quality of the patients with schizophrenia","volume":"21","author":"Zeng","year":"2006","journal-title":"Chinese Journal of Rehabilitation"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB181|cit181","first-page":"429","article-title":"A comparative study of aripiprazole versus olanzapine in the treatment of chronic schizophrenia","volume":"14","author":"Zhang","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB182|cit182","first-page":"635","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"14","author":"Zhang","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"9","key":"10.1002\/14651858.CD006569.pub4-BIB183|cit183","first-page":"753","article-title":"Controlled study on aripiprazole in the treatment of schizophrenic patients who has response to clozapine","volume":"18","author":"Zhang","year":"2006","journal-title":"Medical Journal of Chinese Civil Administration"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub4-BIB184|cit184","first-page":"1016, 1018","article-title":"A comparative study of EKG changed by aripiprazole and clozapine in the treatment of schizophrenia","volume":"19","author":"Zhang","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB185|cit185","first-page":"122","article-title":"A control study of aripiprazole in the treatment of childhood schizophrenia","volume":"13","author":"Zhang","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB186|cit186","first-page":"494","article-title":"Clinical control study of aripiprazole and risperidone in the treatment of first- episode schizophrenia","volume":"23","author":"Zhang","year":"2007","journal-title":"Modern Medicine and Health"},{"issue":"13","key":"10.1002\/14651858.CD006569.pub4-BIB187|cit187","first-page":"1542","article-title":"Comparative investigation on aripiprazole and risperidone in the treatment of schizophrenia","volume":"29","author":"Zhang","year":"2008","journal-title":"Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][\u9f4a \u9f4a \u54c8 \u723e \u91ab \u5b78 \u9662 \u5b78 \u5831 ]"},{"issue":"11","key":"10.1002\/14651858.CD006569.pub4-BIB188|cit188","first-page":"1299","article-title":"Aripiprazole and quetiapine in the treatment control study of first-episode schizophrenia","volume":"17","author":"\u5f20","year":"2009","journal-title":"Chinese Journal of Health Psychology [\u4e2d \u56fd \u5065 \u5eb7 \u5fc3 \u7406 \u5b66 \u6742 \u5fd7 ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB189|cit189","first-page":"762","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia comparative analysis of 100 cases","volume":"18","author":"\u5f20 \u7389 \u6e05","year":"2010","journal-title":"Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease [\u5b9e \u7528 \u5fc3 \u8111 \u80ba \u8840 \u7ba1 \u75c5 \u6742 \u5fd7 ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB190|cit190","first-page":"1033","article-title":"Aripiprazole and clozapine in treatment refractory schizophrenia","volume":"25","author":"\u5f20 \u542f \u6797","year":"2010","journal-title":"West China Medical Journal [\u534e \u897f \u533b \u5b66 ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB191|cit191","first-page":"663","article-title":"A controlled study of aripiprazole versus quetiapine in the treatment of first-episode schizophrenia","volume":"14","author":"Zhao","year":"2006","journal-title":"Chinese Journal of Health Psychology"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB192|cit192","first-page":"195","article-title":"A comparative study of aripiprazole versus risperdal in patients with schizophrenia","volume":"19","author":"Zhao","year":"2007","journal-title":"Medical Journal of Chinese People's Health"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB193|cit193","first-page":"666","article-title":"A control study on effect of domestic aripiprazole and clozapine in treatment of schizophrenia","volume":"25","author":"\u8d75 \u6676 \u5a9b","year":"2009","journal-title":"Occupation and Health [\u804c \u4e1a \u4e0e \u5065 \u5eb7 ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB194|cit194","first-page":"666","article-title":"Domestic aripiprazole and clozapine in the treatment of schizophrenia and safety control study","volume":"25","author":"\u8d75 \u6676 \u5a9b","year":"2009","journal-title":"Occupation and Health [\u804c \u4e1a \u4e0e \u5065 \u5eb7 ]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB195|cit195","first-page":"327","article-title":"Comparative study of aripiprazole and risperidone in treatment of late onset schizophrenia","volume":"17","author":"Zhe","year":"2007","journal-title":"Linchuang Jingshen Yixue Zazhi"},{"issue":"21","key":"10.1002\/14651858.CD006569.pub4-BIB196|cit196","first-page":"2787","article-title":"Comparison study of aripiprazole and risperidone on schizophrenia","volume":"14","author":"Zhi","year":"2005","journal-title":"Modern Journal of Integrated Traditional Chinese and Western Medicine"},{"key":"10.1002\/14651858.CD006569.pub4-BIB197|cit197","first-page":"1194","article-title":"Clinical study of therapeutic effects of aripiprazole in treatment of patients with schizophrenia","volume":"10","author":"Zhu","year":"2005","journal-title":"China"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB198|cit198","first-page":"536","article-title":"Treatment of 40 cases of schizophrenia with aripiprazole","volume":"25","author":"Zhu","year":"2006","journal-title":"Herald of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB199|cit199","first-page":"17","article-title":"Comparative study on effects of aripiprazole and clozapine","volume":"3","author":"Zou","year":"2006","journal-title":"\u4e2d \u534e \u73b0 \u4ee3 \u5185 \u79d1 \u5b66 \u6742 \u5fd7"},{"issue":"17","key":"10.1002\/14651858.CD006569.pub4-BIB200|cit200","first-page":"87","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"45","author":"\u4e01 \u6c38 \u7ea2","year":"2007","journal-title":"\u4e2d \u56fd \u73b0 \u4ee3 \u533b \u751f"},{"issue":"19","key":"10.1002\/14651858.CD006569.pub4-BIB201|cit201","first-page":"2267, 2269","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia\u00a0","volume":"20","author":"\u4e8e \u6c38 \u6d9b","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub4-BIB202|cit202","first-page":"1066","article-title":"Controlled clinical studies of aripiprazole and clozapine in the treatment of schizophrenia\u00a0","volume":"19","author":"\u4f59 \u5fd7 \u521a","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB203|cit203","first-page":"211","article-title":"Aripiprazole and clozapine in the treatment of chronic schizophrenia [Google Translate]","volume":"23","author":"\u4f59 \u745e \u9ad8","year":"2009","journal-title":"Medical Journal of Liaoning"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub4-BIB204|cit204","first-page":"905","article-title":"Comparison of the efficacy of aripiprazole and risperidone in the treatment of schizophrenia\u00a0","volume":"30","author":"\u5170","year":"2009","journal-title":"Sichuan Mental Health [\u56db \u5ddd \u7cbe \u795e \u536b \u751f ]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB205|cit205","first-page":"55","article-title":"Aripiprazole and clozapine treatment episode schizophrenia","volume":"3","author":"\u5218 \u4e95 \u5e74","year":"2008","journal-title":"\u4e2d \u56fd \u5b9e \u7528 \u533b \u836f"},{"issue":"19","key":"10.1002\/14651858.CD006569.pub4-BIB206|cit206","first-page":"110","article-title":"Aripiprazole psychiatric symptoms and quality of life of patients with schizophrenia\u00a0","volume":"5","author":"\u5218 \u4ece \u654f","year":"2008","journal-title":"\u4e2d \u56fd \u533b \u836f \u5bfc \u62a5"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB207|cit207","first-page":"224","article-title":"Aripiprazole and risperidone in the treatment of refractory schizophrenia\u00a0","volume":"20","author":"\u5218 \u4f1f \u950b","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB208|cit208","first-page":"646","article-title":"Clozapine, risperidone and aripiprazole adverse drug reactions cost - effectiveness analysis","volume":"18","author":"\u5218 \u5349 \u5170","year":"2010","journal-title":"Chinese Journal of Health Psychology [\u4e2d \u56fd \u5065 \u5eb7 \u5fc3 \u7406 \u5b66 \u6742 \u5fd7 ]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB209|cit209","first-page":"339","article-title":"Aripiprazole and olanzapine schizophrenia","volume":"22","author":"\u5218","year":"2009","journal-title":"Shandong Archives of Psychiatry [\u5c71 \u4e1c \u7cbe \u795e \u533b \u5b66 ]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB210|cit210","first-page":"276","article-title":"Aripiprazole and risperidone in the treatment episode schizophrenia\u00a0","volume":"25","author":"\u5218 \u5ce5 \u5d58","year":"2008","journal-title":"Chinese Medical Journal of Metallurgical Industry [\u4e2d \u56fd \u51b6 \u91d1 \u5de5 \u4e1a \u533b \u5b66 \u6742 \u5fd7 ]"},{"issue":"9","key":"10.1002\/14651858.CD006569.pub4-BIB211|cit211","first-page":"1072","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia\u00a0","volume":"22","author":"\u5218 \u5fd7 \u4e1c","year":"2009","journal-title":"Journal of Medical Theory and Practice"},{"issue":"9","key":"10.1002\/14651858.CD006569.pub4-BIB212|cit212","first-page":"1072","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"22","author":"\u5218 \u5fd7 \u4e1c","year":"2009","journal-title":"Journal of Medical Theory and Practice"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB213|cit213","first-page":"42","article-title":"Aripiprazole and quetiapine in the treatment of schizophrenia [Google Translate]","volume":"22","author":"\u5218","year":"2009","journal-title":"Shandong Archives of Psychiatry [\u5c71 \u4e1c \u7cbe \u795e \u533b \u5b66 ]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB214|cit214","first-page":"115","article-title":"Clinical comparison of aripiprazole and risperidone in the treatment of female schizophrenia\u00a0","volume":"22","author":"\u5218 \u6653 \u7ea2","year":"2009","journal-title":"Sichuan Mental Health [\u56db \u5ddd \u7cbe \u795e \u536b \u751f ]"},{"issue":"23","key":"10.1002\/14651858.CD006569.pub4-BIB215|cit215","first-page":"2804","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia\u00a0","volume":"20","author":"\u5362 \u8273 \u6625","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB216|cit216","first-page":"384","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia control observation\u00a0","volume":"29","author":"\u5468 \u4f1f \u4e1c","year":"2007","journal-title":"Journal of the Youjiang Medical College for Nationalities"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB217|cit217","first-page":"139","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia\u00a0","volume":"21","author":"\u5468","year":"2008","journal-title":"\u7cbe \u795e \u533b \u5b66 \u6742 \u5fd7"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB218|cit218","first-page":"126","article-title":"Aripiprazole and clozapine treatment of schizophrenia\u00a0","volume":"17","author":"\u5468","year":"2007","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34 \u5e8a \u7cbe \u795e \u533b \u5b66 \u6742 \u5fd7 ]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB219|cit219","first-page":"354, 356","article-title":"Aripiprazole impact on the quality of life in patients with schizophrenia\u00a0","volume":"19","author":"\u5468 \u96e8 \u6797","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"7","key":"10.1002\/14651858.CD006569.pub4-BIB220|cit220","first-page":"774","article-title":"Control study on aripiprazole in the treatment of first-episode schizophrenia","volume":"17","author":"\u5b59","year":"2009","journal-title":"Chinese Journal of Health Psychology [\u4e2d \u56fd \u5065 \u5eb7 \u5fc3 \u7406 \u5b66 \u6742 \u5fd7 ]"},{"key":"10.1002\/14651858.CD006569.pub4-BIB221|cit221","first-page":"1416","article-title":"Quetiapine and aripiprazole in the treatment of schizophrenia","volume":"12","author":"\u5b59 \u5fb7 \u751f","year":"2009","journal-title":"Chinese Journal of Health Psychology [\u4e2d \u56fd \u5065 \u5eb7 \u5fc3 \u7406 \u5b66 \u6742 \u5fd7 ]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB222|cit222","first-page":"381","article-title":"Quetiapine, aripiprazole treatment efficacy in patients with acute schizophrenia","volume":"22","author":"\u5b59","year":"2009","journal-title":"Shandong Archives of Psychiatry [\u5c71 \u4e1c \u7cbe \u795e \u533b \u5b66 ]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB223|cit223","first-page":"34","article-title":"Comparative analysis of aripiprazole and risperidone in the treatment of female schizophrenia\u00a0","volume":"21","author":"\u5b8b \u8273 \u840d","year":"2008","journal-title":"Sichuan Mental Health [\u56db \u5ddd \u7cbe \u795e \u536b \u751f ]"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub4-BIB224|cit224","first-page":"970","article-title":"Olanzapine and aripiprazole in the treatment of schizophrenia","volume":"22","author":"\u5b8b","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"19","key":"10.1002\/14651858.CD006569.pub4-BIB225|cit225","first-page":"67","article-title":"Aripiprazole comparative study of risperidone in the treatment of schizophrenia","volume":"30","author":"\u5b8b \u957f \u60e0","year":"2009","journal-title":"Journal of Medical Forum [\u533b \u836f \u8bba \u575b \u6742 \u5fd7 ]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB226|cit226","first-page":"20","article-title":"Compare the aripiprazole with risperidone to treat schizophrenia disease","volume":"29","author":"\u5d14","year":"2008","journal-title":"Journal of the Mudanjiang Medical College"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB227|cit227","first-page":"343","article-title":"Aripiprazole and risperidone on glucose and lipid","volume":"19","author":"\u5f20 \u4e1c \u536b","year":"2009","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34 \u5e8a \u7cbe \u795e \u533b \u5b66 \u6742 \u5fd7 ]"},{"issue":"14","key":"10.1002\/14651858.CD006569.pub4-BIB228|cit228","first-page":"1703","article-title":"Aripiprazole and clozapine in the treatment of refractory schizophrenia\u00a0","volume":"29","author":"\u5f20 \u4ec1 \u51ef","year":"2008","journal-title":"Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][\u9f4a \u9f4a \u54c8 \u723e \u91ab \u5b78 \u9662 \u5b78 \u5831 ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB229|cit229","first-page":"117","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia\u00a0","volume":"29","author":"\u5f20 \u5c0f \u8046","year":"2007","journal-title":"Fujian Medical Journal [\u798f \u5efa \u533b \u836f \u6742 \u5fd7 ]"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB230|cit230","first-page":"52","article-title":"Controlled clinical observation of aripiprazole and risperidone in the treatment of schizophrenia\u00a0","volume":"39","author":"\u5f20 \u632f \u4e1c","year":"2008","journal-title":"Guangzhou Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB231|cit231","first-page":"41","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"25","author":"\u5f20 \u7075 \u5a25","year":"2009","journal-title":"Journal of Baotou Medical College [\u5305 \u982d \u91ab \u5b78 \u9662 \u5b78 \u5831 ]"},{"issue":"20","key":"10.1002\/14651858.CD006569.pub4-BIB232|cit232","first-page":"2386, 2435","article-title":"Comparison of the efficacy of aripiprazole and risperidone in the treatment of schizophrenia","volume":"20","author":"\u5f20 \u80dc \u5229","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub4-BIB233|cit233","first-page":"822","article-title":"Aripiprazole and clozapine in treatment refractory schizophrenia comparative observation","volume":"52","author":"\u5f20 \u8273 \u7426","year":"2009","journal-title":"People's Military Surgeon [\u4eba \u6c11 \u519b \u533b ]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB234|cit234","first-page":"35","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia randomized double-blind controlled study","volume":"20","author":"\u5f90","year":"2010","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34 \u5e8a \u7cbe \u795e \u533b \u5b66 \u6742 \u5fd7 ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB235|cit235","first-page":"548","article-title":"Aripiprazole and clozapine treatment of schizophrenia analysis\u00a0","volume":"13","author":"\u5f90 \u7f8e \u52e4","year":"2007","journal-title":"Journal of Clinical Psychosomatic Diseases [\u4e34 \u5e8a \u5fc3 \u8eab \u75be \u75c5 \u6742 \u5fd7 ]"},{"issue":"17","key":"10.1002\/14651858.CD006569.pub4-BIB236|cit236","first-page":"2180","article-title":"Aripiprazole and clozapine in the treatment of chronic schizophrenia","volume":"22","author":"\u5f90","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB237|cit237","first-page":"52","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia compared efficacy","volume":"19","author":"\u652f \u80dc \u5229","year":"2010","journal-title":"China Pharmaceuticals [\u4e2d \u570b \u85e5 \u696d ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB238|cit238","first-page":"987","article-title":"Aripiprazole and risperidone in the treatment of female controlled study of schizophrenia","volume":"30","author":"\u6587 \u542f \u7434","year":"2009","journal-title":"Guangdong Medical Journal [\u5e7f \u4e1c \u533b \u5b66 ]"},{"issue":"22","key":"10.1002\/14651858.CD006569.pub4-BIB239|cit239","first-page":"37","article-title":"Aripiprazole and risperidone in patients with first-episode schizophrenia comparative efficacy and safety study","volume":"17","author":"\u664f \u6842 \u840d","year":"2010","journal-title":"\u4e2d \u56fd \u5f53 \u4ee3 \u533b \u836f"},{"key":"10.1002\/14651858.CD006569.pub4-BIB240|cit240","first-page":"33","article-title":"The comparison for effect of treating schizophrenia with aripiprazole and risperidone","volume":"6","author":"\u66f2 \u4e07 \u4ec1","year":"2009","journal-title":"Chinese Journal of Ethnomedicine and Ethnopharmacy"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB241|cit241","first-page":"9","article-title":"Aripiprazole and quetiapine controlled study for the treatment of schizophrenia","volume":"8","author":"\u6731 \u6ee1 \u8fde","year":"2008","journal-title":"Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine [\u5b9e \u7528 \u4e2d \u897f \u533b \u7ed3 \u5408 \u4e34 \u5e8a ]"},{"issue":"9","key":"10.1002\/14651858.CD006569.pub4-BIB242|cit242","first-page":"1709","article-title":"Risperidone and olanzapine and aripiprazole on cognitive function in chronic schizophrenia","volume":"4","author":"\u6731 \u9038 \u6eaa","year":"2010","journal-title":"\u4e2d \u534e \u4e34 \u5e8a \u533b \u5e08 \u6742 \u5fd7 (\u7535 \u5b50 \u7248 )"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB243|cit243","first-page":"13","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia compared [Google Translate]","volume":"33","author":"\u674e \u4ee3 \u79c0","year":"2009","journal-title":"Baotou Medical Journal"},{"issue":"18","key":"10.1002\/14651858.CD006569.pub4-BIB244|cit244","first-page":"166","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"4","author":"\u674e \u6653 \u534e","year":"2009","journal-title":"\u4e2d \u56fd \u5b9e \u7528 \u533b \u836f"},{"issue":"16","key":"10.1002\/14651858.CD006569.pub4-BIB245|cit245","first-page":"135","article-title":"Aripiprazole and clozapine treatment of schizophrenia control study of efficacy and safety","volume":"25","author":"\u674e \u6653 \u82f1","year":"2009","journal-title":"\u7518 \u8083 \u79d1 \u6280"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub4-BIB246|cit246","first-page":"1064, 1067","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia\u00a0","volume":"19","author":"\u674e","year":"2007","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"11A","key":"10.1002\/14651858.CD006569.pub4-BIB247|cit247","first-page":"49","article-title":"Aripiprazole and quetiapine in the treatment of schizophrenia\u00a0","volume":"30","author":"\u674e \u7f8e \u82b1","year":"2007","journal-title":"\u4e2d \u56fd \u533b \u5e08 \u8fdb \u4fee \u6742 \u5fd7"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB248|cit248","first-page":"391","article-title":"Aripiprazole and clozapine in the treatment of schizophrenia","volume":"23","author":"\u674e","year":"2010","journal-title":"Acta Medicinae Sinica [\u534e \u590f \u533b \u5b66 ]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB249|cit249","first-page":"339","article-title":"Aripiprazole and olanzapine on body weight, blood glucose control study effects","volume":"19","author":"\u6768 \u6625 \u5f3a","year":"2009","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34 \u5e8a \u7cbe \u795e \u533b \u5b66 \u6742 \u5fd7 ]"},{"issue":"13","key":"10.1002\/14651858.CD006569.pub4-BIB250|cit250","first-page":"100","article-title":"Aripiprazole in the treatment of female schizophrenia\u00a0","volume":"46","author":"\u6768","year":"2008","journal-title":"\u4e2d \u56fd \u73b0 \u4ee3 \u533b \u751f"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB251|cit251","first-page":"38","article-title":"Control study of aripiprazole and clozapine in the treatment of the negative symptoms of schizophrenia\u00a0","volume":"22","author":"\u6797","year":"2009","journal-title":"Sichuan Mental Health [\u56db \u5ddd \u7cbe \u795e \u536b \u751f ]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB252|cit252","first-page":"38","article-title":"Aripiprazole and clozapine in the treatment of negative symptoms of schizophrenia","volume":"22","author":"\u6797","year":"2009","journal-title":"Sichuan Mental Health [\u56db \u5ddd \u7cbe \u795e \u536b \u751f ]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB253|cit253","first-page":"313","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"20","author":"\u6817 \u5c0f \u7ea2","year":"2007","journal-title":"Shandong Archives of Psychiatry [\u5c71 \u4e1c \u7cbe \u795e \u533b \u5b66 ]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB254|cit254","first-page":"30","article-title":"Compliance control study of aripiprazole and risperidone in the treatment of patients with schizophrenia","volume":"30","author":"\u6881","year":"2008","journal-title":"Guangxi Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD006569.pub4-BIB255|cit255","first-page":"1365","article-title":"Olanzapine and aripiprazole in the treatment of refractory schizophrenia control study of 70 cases","volume":"22","author":"\u6bdb","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"key":"10.1002\/14651858.CD006569.pub4-BIB256|cit256","first-page":"641","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"3","author":"\u6c90 \u5fd7 \u5f3a","year":"2010","journal-title":"Medical Information"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub4-BIB257|cit257","first-page":"799","article-title":"Aripiprazole (Booz Qing) and risperidone in the treatment of schizophrenia in the clinical control study","volume":"44","author":"\u6d82 \u56fd \u548c","year":"2009","journal-title":"Jiangxi Medical Journal [\u6c5f \u897f \u533b \u836f ]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB258|cit258","first-page":"110","article-title":"Aripiprazole in the treatment of schizophrenia clinical observation","volume":"21","author":"\u738b \u56fd \u5bcc","year":"2007","journal-title":"Journal of the Changzhi Medical College"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB259|cit259","first-page":"206","article-title":"Ziprasidone treatment of schizophrenia with predominantly negative symptoms","volume":"18","author":"\u738b \u5929 \u9f99","year":"2008","journal-title":"Linchuang Jingshen Yixue Zazhi [\u4e34 \u5e8a \u7cbe \u795e \u533b \u5b66 \u6742 \u5fd7 ]"},{"issue":"11","key":"10.1002\/14651858.CD006569.pub4-BIB260|cit260","first-page":"44","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"4","author":"\u738b \u5b66 \u6ee8","year":"2007","journal-title":"\u4e2d \u5916 \u5065 \u5eb7 \u6587 \u6458 [\u533b \u836f \u5b66 \u520a ]"},{"issue":"14","key":"10.1002\/14651858.CD006569.pub4-BIB261|cit261","first-page":"1752","article-title":"New antipsychotic drug aripiprazole on glucose metabolism and glycosylated hemoglobin\u00a0\u00a0","volume":"31","author":"\u738b \u8302 \u840d","year":"2009","journal-title":"Hebei Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB262|cit262","first-page":"199","article-title":"Ziprasidone and aripiprazole in the treatment of schizophrenia","volume":"41","author":"\u767d \u5251 \u6587","year":"2009","journal-title":"\u9752 \u5c9b \u533b \u836f \u536b \u751f"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB263|cit263","first-page":"284, 300","article-title":"Aripiprazole and risperidone in the treatment of chronic schizophrenia\u00a0","volume":"20","author":"\u79e6 \u7231 \u73b2","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB264|cit264","first-page":"106","article-title":"Ziprasidone and aripiprazole in the treatment of schizophrenia with predominantly negative symptoms\u00a0","volume":"23","author":"\u7a0b","year":"2009","journal-title":"Journal of the Xianning Medical College [\u65b0 \u4e61 \u533b \u5b66 \u9662 \u5b66 \u62a5 ]"},{"issue":"23","key":"10.1002\/14651858.CD006569.pub4-BIB265|cit265","first-page":"2781, 2783","article-title":"Domestic aripiprazole and risperidone in the treatment of female schizophrenia\u00a0","volume":"20","author":"\u7a46 \u5fb7 \u519b","year":"2008","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"170","key":"10.1002\/14651858.CD006569.pub4-BIB266|cit266","first-page":"101","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia efficacy analysis\u00a0","volume":"15","author":"\u7f57 \u6765 \u5174","year":"2009","journal-title":"\u5f53 \u4ee3 \u533b \u5b66"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB267|cit267","first-page":"407","article-title":"Comparative study of the effects of ariplprazole and risoeridone on the therapeutic effect and patients\u2019 weight in patients with schizophrenia","volume":"31","author":"\u803f \u5bd2 \u677e","year":"2009","journal-title":"Hebei Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB268|cit268","first-page":"41","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"22","author":"\u80e1 \u4e9a \u6e58","year":"2010","journal-title":"Tianjin Pharmacy"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB269|cit269","first-page":"1051","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"22","author":"\u8303 \u6587 \u6f9c","year":"2010","journal-title":"\u897f \u90e8 \u533b \u5b66"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB270|cit270","first-page":"46","article-title":"Aripiprazole and quetiapine in the treatment of women with schizophrenia","volume":"13","author":"\u845b \u6dd1 \u541b","year":"2010","journal-title":"Chinese General Practice [\u4e2d \u56fd \u5168 \u79d1 \u533b \u5b66 ]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB271|cit271","first-page":"87","article-title":"Aripiprazole and clozapine in treatment refractory schizophrenia randomized controlled study","volume":"38","author":"\u848b \u56fd \u5e86","year":"2009","journal-title":"Chongqing Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB272|cit272","first-page":"71","article-title":"Quetiapine and aripiprazole in the treatment control study of first-episode schizophrenia","volume":"2","author":"\u8881 \u7eaf \u73b2","year":"2009","journal-title":"\u4e2d \u56fd \u73b0 \u4ee3 \u836f \u7269 \u5e94 \u7528"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB273|cit273","first-page":"1111","article-title":"Aripiprazole and risperidone in the treatment of male schizophrenia efficacy and sexual function","volume":"25","author":"\u8c22 \u65b0 \u5e74","year":"2008","journal-title":"Hunan Medical Journal"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB274|cit274","first-page":"190","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"11","author":"\u8c22 \u6839 \u751f","year":"2010","journal-title":"\u4e2d \u56fd \u9884 \u9632 \u533b \u5b66 \u6742 \u5fd7"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB275|cit275","first-page":"221","article-title":"Aripiprazole and risperidone on serum prolactin levels","volume":"23","author":"\u8d75 \u8d35 \u6587","year":"2009","journal-title":"Medical Journal of Liaoning"},{"issue":"14","key":"10.1002\/14651858.CD006569.pub4-BIB276|cit276","first-page":"91","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia\u00a0","volume":"46","author":"\u8fde \u6811 \u594e","year":"2008","journal-title":"\u4e2d \u56fd \u73b0 \u4ee3 \u533b \u751f"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB277|cit277","first-page":"28","article-title":"Effects were compared aripiprazole in the treatment of elderly schizophrenia\u00a0","volume":"21","author":"\u9093 \u514b \u6587","year":"2008","journal-title":"Sichuan Mental Health [\u56db \u5ddd \u7cbe \u795e \u536b \u751f ]"},{"key":"10.1002\/14651858.CD006569.pub4-BIB278|cit278","first-page":"755","article-title":"Control study of domestic aripiprazole and risperidone in the treatment of schizophrenia\u00a0","volume":"5","author":"\u9093","year":"2008","journal-title":"Journal of the Youjiang Medical College for Nationalities"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB279|cit279","first-page":"457","article-title":"Aripiprazole in the treatment of schizophrenia, efficacy and safety analysis\u00a0","volume":"20","author":"\u90d1 \u5b5d \u8363","year":"2008","journal-title":"Modern Practical Medicine"},{"issue":"19","key":"10.1002\/14651858.CD006569.pub4-BIB280|cit280","first-page":"28","article-title":"Aripiprazole and olanzapine treatment of female control study of patients with schizophrenia","volume":"1","author":"\u94b1 \u6587 \u80dc","year":"2009","journal-title":"\u5175 \u56e2 \u533b \u5b66"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB281|cit281","first-page":"465","article-title":"Aripiprazole and risperidone in the treatment of children with schizophrenia","volume":"27","author":"\u95eb \u51e4 \u5a1f","year":"2008","journal-title":"\u4e2d \u56fd \u533b \u5b66 \u6587 \u6458 [\u513f \u79d1 \u5b66 ]"},{"issue":"18","key":"10.1002\/14651858.CD006569.pub4-BIB282|cit282","first-page":"4304","article-title":"Aripiprazole and clozapine treatment of refractory schizophrenia\u00a0","volume":"8","author":"\u95eb \u5b9d \u660c","year":"2008","journal-title":"Chinese Journal of Misdiagnostics [\u4e2d \u56fd \u8bef \u8bca \u5b66 \u6742 \u5fd7 ]"},{"issue":"11c","key":"10.1002\/14651858.CD006569.pub4-BIB283|cit283","first-page":"15","article-title":"Aripiprazole impact on the quality of life of patients with schizophrenia","volume":"5","author":"\u960e \u7f8e \u82f1","year":"2007","journal-title":"\u5bb6 \u5ead \u62a4 \u58eb"},{"issue":"17","key":"10.1002\/14651858.CD006569.pub4-BIB284|cit284","first-page":"2249","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"22","author":"\u5510","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"17","key":"10.1002\/14651858.CD006569.pub4-BIB285|cit285","first-page":"2243","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia in the clinical control study","volume":"22","author":"\u9648 \u5e73 \u52cb","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"9B","key":"10.1002\/14651858.CD006569.pub4-BIB286|cit286","first-page":"1232","article-title":"Aripiprazole and risperidone in the treatment of female schizophrenia","volume":"19","author":"\u9648 \u6c38 \u7ea2","year":"2010","journal-title":"Shanxi Clinical Medicine"},{"issue":"15","key":"10.1002\/14651858.CD006569.pub4-BIB287|cit287","first-page":"1939","article-title":"Aripiprazole and clozapine on quality of life of patients with schizophrenia","volume":"22","author":"\u9648","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB288|cit288","first-page":"53","article-title":"Aripiprazole and quetiapine in the treatment of schizophrenia","volume":"22","author":"\u9648 \u7ea2 \u82f1","year":"2009","journal-title":"Shandong Archives of Psychiatry [\u5c71 \u4e1c \u7cbe \u795e \u533b \u5b66 ]"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB289|cit289","first-page":"140","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia","volume":"16","author":"\u9648 \u8389 \u6676","year":"2010","journal-title":"\u5f53 \u4ee3 \u533b \u5b66"},{"issue":"35","key":"10.1002\/14651858.CD006569.pub4-BIB290|cit290","first-page":"5454","article-title":"Aripiprazole and risperidone in the treatment of female schizophrenia\u00a0","volume":"17","author":"\u9648 \u9707 \u96f7","year":"2008","journal-title":"Modern Research of Integrated Chinese and Western Medicine [\u73b0 \u4ee3 \u4e2d \u897f \u533b \u7ed3 \u5408 \u6742 \u5fd7 ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB291|cit291","first-page":"381","article-title":"Aripiprazole, quetiapine treatment of female episode schizophrenia\u00a0","volume":"20","author":"\u9648","year":"2007","journal-title":"Shandong Archives of Psychiatry [\u5c71 \u4e1c \u7cbe \u795e \u533b \u5b66 ]"},{"key":"10.1002\/14651858.CD006569.pub4-BIB292|cit292","series-title":"Proceedings of the 8th National Academic Congress of CSP with the Regional Meeting of the WPA; 2007 Sep 20-23; Shanghai","article-title":"A controlled study on compliance of schizophrenia treated with aripiprazole and risperidone","author":"\u9676 \u5efa \u9752","year":"2007"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB293|cit293","first-page":"39","article-title":"Comparative Analysis of aripiprazole and risperidone in the treatment of schizophrenia negative emotions\u00a0","volume":"22","author":"\u515a \u8fde \u8363","year":"2009","journal-title":"Sichuan Mental Health [\u56db \u5ddd \u7cbe \u795e \u536b \u751f ]"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB294|cit294","first-page":"39","article-title":"Aripiprazole and risperidone in the treatment of schizophrenia comparative analysis of negative emotion","volume":"22","author":"\u97a0","year":"2009","journal-title":"Sichuan Mental Health [\u56db \u5ddd \u7cbe \u795e \u536b \u751f ]"},{"issue":"9","key":"10.1002\/14651858.CD006569.pub4-BIB295|cit295","first-page":"1379","article-title":"Second generation of psychiatric drugs 3 cost of the treatment of schizophrenia","volume":"31","author":"\u97e9 \u60e0 \u82ac","year":"2010","journal-title":"Journal of Qiqihar Medical College [Qiqihar Yixueyuan xuebao][\u9f4a \u9f4a \u54c8 \u723e \u91ab \u5b78 \u9662 \u5b78 \u5831 ]"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB296|cit296","first-page":"511","article-title":"Aripiprazole and quetiapine in the treatment of schizophrenia control study of women","volume":"22","author":"\u97e9 \u6811 \u534e","year":"2010","journal-title":"Medical Journal of Chinese People's Health [\u4e2d \u56fd \u6c11 \u5eb7 \u533b \u5b66 ]"},{"issue":"31","key":"10.1002\/14651858.CD006569.pub4-BIB297|cit297","first-page":"4298","article-title":"Aripiprazole and risperidone in the treatment of clinical studies of schizophrenia\u00a0","volume":"14","author":"\u97e9 \u96ea \u5cf0","year":"2007","journal-title":"Journal of Practical Medical Techniques [\u5b9e \u7528 \u533b \u6280 \u6742 \u5fd7 ]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB298|cit298","first-page":"107","article-title":"Aripiprazole and clozapine treatment of schizophrenia with predominantly negative symptoms","volume":"21","author":"\u9889","year":"2008","journal-title":"Sichuan Mental Health [\u56db \u5ddd \u7cbe \u795e \u536b \u751f ]"},{"issue":"6","key":"10.1002\/14651858.CD006569.pub4-BIB299|cit299","first-page":"643","article-title":"Efficacy of aripiprazole and risperidone in the treatment of early schizophrenia\u00a0","volume":"17","author":"\u9a6c \u5fe0 \u667a","year":"2009","journal-title":"Chinese Journal of Health Psychology [\u4e2d \u56fd \u5065 \u5eb7 \u5fc3 \u7406 \u5b66 \u6742 \u5fd7 ]"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB300|cit300","first-page":"77","article-title":"Comparative study on aripiprazole and risperidone in the treatment of female patients with schizophrenics","volume":"12","author":"\u9a6c \u95ef \u80dc","year":"2009","journal-title":"\u5b9e \u7528 \u836f \u7269 \u4e0e \u4e34 \u5e8a"},{"issue":"16","key":"10.1002\/14651858.CD006569.pub4-BIB301|cit301","first-page":"166","article-title":"Olanzapine and aripiprazole treatment of schizophrenia","volume":"4","author":"\u9b4f \u4e3d \u971e","year":"2009","journal-title":"\u4e2d \u56fd \u5b9e \u7528 \u533b \u836f"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB302|cit302","first-page":"80","article-title":"Control study of aripiprazole and clozapine in schizophrenia affect the quality of life in patients","volume":"20","author":"\u9b4f \u6708 \u73b2","year":"2007","journal-title":"Sichuan Mental Health [\u56db \u5ddd \u7cbe \u795e \u536b \u751f ]"},{"issue":"23","key":"10.1002\/14651858.CD006569.pub4-BIB303|cit303","first-page":"59","article-title":"Aripiprazole and olanzapine in negative symptoms in schizophrenia","volume":"18","author":"\u9ebb \u663e \u5a07","year":"2009","journal-title":"China Pharmaceuticals [\u4e2d \u570b \u85e5 \u696d ]"},{"issue":"142","key":"10.1002\/14651858.CD006569.pub4-BIB304|cit304","first-page":"54","article-title":"Aripiprazole impact on the quality of life of the first female schizophrenic patients\u00a0","volume":"24","author":"\u9ec4 \u627f \u7e41","year":"2009","journal-title":"Chinese Journal of Health Psychology [\u4e2d \u56fd \u5065 \u5eb7 \u5fc3 \u7406 \u5b66 \u6742 \u5fd7 ]"},{"issue":"16","key":"10.1002\/14651858.CD006569.pub4-BIB305|cit305","first-page":"15","article-title":"A comparative study in earlier schizophrenic patients treated with aripiprazole and risperidone","volume":"7","author":"\u9ec4 \u6cb3 \u4eae","year":"2009","journal-title":"\u4e2d \u56fd \u533b \u836f \u6307 \u5357"},{"key":"10.1002\/14651858.CD006569.pub4-BIB306|cit306","unstructured":"Bristol-Myers Squibb Metabolic abnormalities - OPT http:\/\/www.clinicaltrials.gov 2009"},{"key":"10.1002\/14651858.CD006569.pub4-BIB307|cit307","unstructured":"Eli Lilly Company Study of olanzapine vs aripiprazole in the treatment of schizophrenia Eli Lilly and Company Clinical Trial Registry 2003"},{"key":"10.1002\/14651858.CD006569.pub4-BIB308|cit308","unstructured":"Essock SM Covell NH Carbuto M Bielen K Jabbour B Saltz BL Effectiveness of switching antipsychotic medications http:\/\/www.clinicaltrials.gov 2002"},{"key":"10.1002\/14651858.CD006569.pub4-BIB309|cit309","unstructured":"Glorioso DK Jeste DV Metabolic effects of newer antipsychotics in older patients http:\/\/www.clinicaltrials.gov 2005"},{"key":"10.1002\/14651858.CD006569.pub4-BIB310|cit310","unstructured":"Hanssens L A 16-Week, multicenter, randomized, open-label study to assess the effects of aripiprazole versus other atypical antipsychotics in the treatment of schizophrenic patients with metabolic syndrome http:\/\/www.clinicaltrials.gov 2007"},{"key":"10.1002\/14651858.CD006569.pub4-BIB311|cit311","unstructured":"Johnson & Johnson Pharmaceutical Research & Development LLC A 2-year, prospective, blinded-rater, open-label, active-controlled, multicenter, randomized study of long-term efficacy and effectiveness comparing risperdal\u00ae consta\u00ae and abilify\u00ae (aripiprazole) in adults with schizophrenia http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub4-BIB312|cit312","unstructured":"Lehrer DS Jewell M Best event schizophrenia trial--a randomized double-blind trial of aripiprazole and risperidone in schizophrenia http:\/\/www.clinicaltrials.gov 2008"},{"key":"10.1002\/14651858.CD006569.pub4-BIB313|cit313","unstructured":"Lin C-C Identification and treatment response prediction of antipsychotic-related metabolic syndrome http:\/\/www.clinicaltrials.gov 2009"},{"key":"10.1002\/14651858.CD006569.pub4-BIB314|cit314","unstructured":"Livingston M Stroup TS McEvoy JP Rojas I Gamel N Glick I Clinical management of metabolic problems in patients with schizophrenia http:\/\/www.clinicaltrials.gov 2007"},{"key":"10.1002\/14651858.CD006569.pub4-BIB315|cit315","unstructured":"McCormack J Robinson D Tobias K Petrides G Robinson D Sevy S Preventing morbidity in first episode schizophrenia, part II http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub4-BIB316|cit316","unstructured":"McEvoy JP Metabolic signatures and biomarkers for aripiprazole http:\/\/www.clinicaltrials.gov 2007"},{"key":"10.1002\/14651858.CD006569.pub4-BIB317|cit317","unstructured":"Montoya D Blizard R Buckley PF Holman T Kerr J Miller DD Preventing relapse: oral antipsychotics compared to injectables: evaluating efficacy (PROACTIVE) http:\/\/www.clinicaltrials.gov 2006"},{"key":"10.1002\/14651858.CD006569.pub4-BIB318|cit318","unstructured":"Schweiger J Flavin K Rosen B Spies A Newcomer JW Haupt D Changes in adiposity and metabolic measures during medication switches to aripiprazole from other atypical antipsychotics http:\/\/www.clinicaltrials.gov 2005"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB319|cit319","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3371\/CSRP.1.1.6","article-title":"Comparison of antipsychotics for metabolic problems (CAMP): a NIMH schizophrenia trials network study","volume":"1","author":"Stroup","year":"2007","journal-title":"Clinical Schizophrenia and Related Psychoses"},{"key":"10.1002\/14651858.CD006569.pub4-BIB320|cit320","doi-asserted-by":"crossref","unstructured":"Swartz M Stroup TS McEvoy JP Rojas IA Comparison of optimal antipsychotic treatments for adults with schizophrenia http:\/\/www.clinicaltrials.gov 2008","DOI":"10.1037\/e645452010-001"},{"key":"10.1002\/14651858.CD006569.pub4-BIB321|cit321","unstructured":"Vontur MG Lopez J Woolsey MD Maples NL Velligan DI Do patients taking aripiprazole learn more in vocational skills training than patients taking olanzapine? http:\/\/www.clinicaltrials.gov 2005"},{"key":"10.1002\/14651858.CD006569.pub4-BIB322|cit322","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006569.pub4-BIB323|cit323","first-page":"1","article-title":"Practice guidelines for the treatment of patients with schizophrenia","volume-title":"American Journal of Psychiatry","year":"2004"},{"key":"10.1002\/14651858.CD006569.pub4-BIB324|cit324","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0893-133X(97)00112-7","article-title":"Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence","volume":"18","author":"Arnt","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB325|cit325","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD006569.pub4-BIB326|cit326","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006622.pub2","article-title":"Aripiprazole versus placebo for schizophrenia","author":"Belgamwar Ravindra","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB327|cit327","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006617.pub2","article-title":"Aripiprazole versus typical antipsychotic drugs for schizophrenia","author":"Bhattacharjee","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub4-BIB328|cit328","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB329|cit329","first-page":"405","article-title":"The problem of therapeutic efficacy indices.3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD006569.pub4-BIB330|cit330","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB331|cit331","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.pra.0000314317.79544.b4","article-title":"Evaluation of the use of the positive and negative syndrome scale-excited component as a criterion for administration of p. r. n. medication","volume":"14","author":"Chaichan","year":"2008","journal-title":"Journal of Psychiatric Practice"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB332|cit332","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0447.2007.01027.x","article-title":"Schizophrenia trials in China: a survey","volume":"116","author":"Chakrabarti","year":"2007","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB333|cit333","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006324.pub2","article-title":"Clozapine combined with different antipsychotic drugs for treatment resistant schizophrenia","author":"Cipriani","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub4-BIB334|cit334","doi-asserted-by":"crossref","unstructured":"Clarke M Can you believe what you read in the papers? Trials 2009 55","DOI":"10.1186\/1745-6215-10-55"},{"key":"10.1002\/14651858.CD006569.pub4-BIB335|cit335","series-title":"Proceeding of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa","article-title":"Issues in the selection for meta-analyses of binary data","author":"Deeks","year":"2000"},{"key":"10.1002\/14651858.CD006569.pub4-BIB336|cit336","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD006569.pub4-BIB337|cit337","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1002\/sim.1301","article-title":"Issues in the meta-analysis of cluster randomized trials","volume":"21","author":"Donner","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB338|cit338","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001359.pub2","article-title":"Olanzapine for schizophrenia","author":"Duggan","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub4-BIB339|cit339","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"13","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB340|cit340","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004578.pub3","article-title":"Aripiprazole for schizophrenia","author":"El-Sayeh","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB341|cit341","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB342|cit342","unstructured":"U. S. Federal Drug Administration CDER Abilify (aripiprazole) tablets, medical review www.fda.gov\/cder\/foi\/nda\/2002\/21-436_Abilify.htm 2002"},{"key":"10.1002\/14651858.CD006569.pub4-BIB343|cit343","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB344|cit344","unstructured":"Gaebel W Falkai P Weinmann S Wobrock T Treatment guidelines for schizophrenia Steinkopf 2006"},{"key":"10.1002\/14651858.CD006569.pub4-BIB345|cit345","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB346|cit346","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"issue":"3","key":"10.1002\/14651858.CD006569.pub4-BIB347|cit347","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/schbul\/10.3.388","article-title":"The quality of life scale: An instrument for rating the schizophrenic deficit syndrome","volume":"10","author":"Heinrichs","year":"1984","journal-title":"Schizophrenia Bulletin"},{"key":"10.1002\/14651858.CD006569.pub4-BIB348|cit348","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1176\/appi.ajp.163.2.185","article-title":"Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine","volume":"163","author":"Heres","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub4-BIB349|cit349","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006569.pub4-BIB350|cit350","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org 2011"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB351|cit351","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2141.2009.07707.x","article-title":"Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials","volume":"146","author":"Hutton","year":"2009","journal-title":"British Journal of Haematology"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB352|cit352","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4314\/cajm.v47i1.8584","article-title":"The reliability of the Shona version of the EQ-5D","volume":"47","author":"Jelsma","year":"2001","journal-title":"Central African Journal of Medicine"},{"key":"10.1002\/14651858.CD006569.pub4-BIB353|cit353","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life","volume":"63","author":"Jones","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub4-BIB354|cit354","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment of treatment-resistant schizophrenia: a double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub4-BIB355|cit355","first-page":"585","article-title":"Treatment programme and long-term outcome in chronic schizophrenia","volume":"46","author":"Kane","year":"1993","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD006569.pub4-BIB356|cit356","volume-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB357|cit357","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1023\/A:1015081805439","article-title":"Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample","volume":"11","author":"Kolotkin","year":"2002","journal-title":"Quality of Life Research"},{"key":"10.1002\/14651858.CD006569.pub4-BIB358|cit358","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD006569.pub4-BIB359|cit359","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB360|cit360","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/schbul\/sbl025","article-title":"Is the superior efficacy of new generation antipsychotics an artifact of LOCF?","volume":"33","author":"Leucht","year":"2007","journal-title":"Schizophrenia Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB361|cit361","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1176\/appi.ajp.2008.08030368","article-title":"A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia","volume":"166","author":"Leucht","year":"2009","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub4-BIB362|cit362","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Liebermann","year":"2005","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB363|cit363","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009005","article-title":"Antipsychotic combinations for schizophrenia","author":"Maayan","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub4-BIB364|cit364","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales - a major source of bias in randomised controlled trials of treatments for schizophrenia?","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006569.pub4-BIB365|cit365","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","article-title":"Schizophrenia and employment - a review","volume":"39","author":"Marvaha","year":"2004","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB366|cit366","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/009262300278623","article-title":"The Arizona Sexual Experience Scale (ASEX): reliability and validity","volume":"26","author":"McGahuey","year":"2000","journal-title":"Journal of Sex & Marital Therapy"},{"key":"10.1002\/14651858.CD006569.pub4-BIB367|cit367","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/jama.285.15.1987","article-title":"The CONSORT Statement: revised recommendations for improving the quality of reports of parallel- group randomized trials","volume":"285","author":"Moher","year":"2001","journal-title":"JAMA"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub4-BIB368|cit368","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006629.pub2","article-title":"Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems","author":"Mukundan","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub4-BIB369|cit369","first-page":"329","article-title":"New assessment of atypical antipsychotics","volume":"71","author":"M\u00f6ller","year":"2000","journal-title":"Nervenarzt"},{"key":"10.1002\/14651858.CD006569.pub4-BIB370|cit370","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB371|cit371","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008074","article-title":"Aripiprazole for psychosis-induced aggression or agitation","author":"Pagadala","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD006569.pub4-BIB372|cit372","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000088.pub3","article-title":"Family intervention for schizophrenia","author":"Pharoah","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006569.pub4-BIB373|cit373","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1037\/0735-7028.34.1.108","article-title":"Aripiprazole: A novel antipsychotic with dopamine stabilising properties","volume":"34","author":"Rivas-Vasquez","year":"2003","journal-title":"Professional Psychology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB374|cit374","volume-title":"Modern Psychometrics","author":"Rust","year":"1989"},{"key":"10.1002\/14651858.CD006569.pub4-BIB375|cit375","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"key":"10.1002\/14651858.CD006569.pub4-BIB376|cit376","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal adverse effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"2-3","key":"10.1002\/14651858.CD006569.pub4-BIB377|cit377","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.psychres.2005.05.006","article-title":"Validation of the investigator's assessment questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder","volume":"136","author":"Tandon","year":"2005","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD006569.pub4-BIB378|cit378","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2008.04.011","article-title":"Schizophrenia, \"just the facts\"What we know in 2008.2. Epidemiology and etiology","volume":"102","author":"Tandon","year":"2008","journal-title":"Schizophrenia Research"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB379|cit379","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jclinepi.2008.12.011","article-title":"A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers","volume":"62","author":"Thorpe","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD006569.pub4-BIB380|cit380","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.1978.01770260031002","article-title":"Suicide in schizophrenics, manics, depressives, and surgical controls: a comparison with general population suicide mortality","volume":"35","author":"Tsuang","year":"1978","journal-title":"Archives of General Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006569.pub4-BIB381|cit381","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"issue":"2","key":"10.1002\/14651858.CD006569.pub4-BIB382|cit382","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002305","article-title":"Antidepressants for people with both schizophrenia and depression","author":"Whitehead","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006569.pub4-BIB383|cit383","volume-title":"The World Health Report 2001 - Mental Health: New Understanding, New Hope","author":"WHO","year":"2001"},{"key":"10.1002\/14651858.CD006569.pub4-BIB384|cit384","series-title":"Proceedings of the 15th Cochrane Colloquium, Sao Paulo, 23-27 October 2007","article-title":"The Leeds Outcomes Stakeholders Survey (LOSS) study","author":"Xia","year":"2007"},{"issue":"7","key":"10.1002\/14651858.CD006569.pub4-BIB385|cit385","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD006569.pub4-BIB386|cit386","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006569.pub3","article-title":"Aripiprazole versus other atypical antipsychotics for schizophrenia","author":"Komossa","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006569.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,1,2]],"date-time":"2014-01-02T00:00:00Z","timestamp":1388620800000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD006569.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:01:13Z","timestamp":1628546473000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006569.pub4"}},"subtitle":[],"editor":[{"given":"Priya","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,2,28]]},"references-count":386,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006569.pub4","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD006569.pub5","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2013,2,28]]}}}